Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 24,083 shares at $0.11 ($3K) on 2016-07-25, disclosed to the SEC on 2016-07-26.
Open-market purchase of $3k LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.11 | 19,083 | $2K | 73.7% |
| 2 | $0.15 | 5,000 | $750 | 26.3% |
| Total | $0.12 avg | 24,083 | $3K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |